Announcements Trials

Browse Landscape

Phase

Phase 2 6 Phase 1 5 Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Solid Tumors 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1

Interventions

Interleukin-2 3 pazopanib 2 lenvatinib 2 aldesleukin 2 Nivolumab 2 Nephrectomy 2 Metastasectomy 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 Fluorodeoxyglucose F18 2 Cryosurgery 2 Biopsy 2 tremelimumab 1 spartalizumab 1 pembrolizumab 1 gallium 68 PSMA-11 1 enzalutamide 1 denileukin diftitox 1 daratumumab 1 clevudine 1 canakinumab 1 cabozantinib 1 Sorafenib 1 Microscopy, Electron 1 Isoflavones 1 Immunoglobulin G 1 Genistein 1 FS 069 1 FAPI-46 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Carcinoma, Renal Cell × spartalizumab × Clear all

NCT04028245 2026-04-15

SPARC-1

Columbia University

Phase EARLY_PHASE1 Completed

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡